Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of Alberta

$219,404.00

Cardiovascular risk among cancer survivors

FY 2013-14

Summary
Although modern drug treatments for cancer have helped many patients live longer and ore productive lives, their side effects are incompletely understood. As cancer survivors now live longer due to these improvements in care, the potential importance of such side effects is increasing over time. A small number of previous studies suggest that older anticancer drugs may increase the risk of heart disease and stroke among cancer survivors. Whether these studies apply to the types of patients treated today (and the types of treatment used in contemporary practice) is unknown. We will use a large database of Alberta patients to assess whether the risk of heart disease and stroke is increased in cancer survivors, compared to otherwise similar people. We will identify other risk factors for cardiovascular disease (besides cancer and its treatment) such as high blood pressure and diabetes among cancer survivors. This study will help doctors to identify new opportunities to improve the health of cancer survivors, by using preventive treatments that reduce the risk of heart attach and stroke in those who are at especially high risk of these conditions.
Program
Operating Grant
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
290608
Name
Tonelli Marcello
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
Cardiovascular risk among cancer survivors
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$219,404
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cancer; Chemotherapy; Epidemiological Study; Heart Disease; Stroke
Abstract
Although modern drug treatments for cancer have helped many patients live longer and ore productive lives, their side effects are incompletely understood. As cancer survivors now live longer due to these improvements in care, the potential importance of such side effects is increasing over time. A small number of previous studies suggest that older anticancer drugs may increase the risk of heart disease and stroke among cancer survivors. Whether these studies apply to the types of patients treated today (and the types of treatment used in contemporary practice) is unknown. We will use a large database of Alberta patients to assess whether the risk of heart disease and stroke is increased in cancer survivors, compared to otherwise similar people. We will identify other risk factors for cardiovascular disease (besides cancer and its treatment) such as high blood pressure and diabetes among cancer survivors. This study will help doctors to identify new opportunities to improve the health of cancer survivors, by using preventive treatments that reduce the risk of heart attach and stroke in those who are at especially high risk of these conditions.
Competitiondate
201309
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tonelli, Marcello
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $219,404~ $0~
University of Alberta - $219,404 Grant (2013-14) | Canada Spends